Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

4

Portfolio Exits

2

About Merlin BioSciences

Merlin Biosciences Limited is a venture capital firm specializing in life sciences sector with a focus on human medicines or medical devices. It prefers to be an active investor and seeks to take a seat on the board of directors of its portfolio companies. Merlin BioSciences changed its name to Excalibur Fund Managers Limited.

Merlin BioSciences Headquarter Location

Berkeley Square House, Berkeley Square Mayfair

London, England, W1J 6BD,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Merlin BioSciences Investments

4 Investments

Merlin BioSciences has made 4 investments. Their latest investment was in Neurotech as part of their Series C - II on March 3, 2010.

CBI Logo

Merlin BioSciences Investments Activity

investments chart

Merlin BioSciences Portfolio Exits

2 Portfolio Exits

Merlin BioSciences has 2 portfolio exits. Their latest portfolio exit was Neurotech on November 12, 2012.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/12/2012

Acquired

1

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

11/12/2012

00/00/0000

Exit

Acquired

Subscribe to see more

Companies

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.